Classification criteria for secondary Sjögren’s syndrome. Current state of knowledge
Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Poland
East Kent Hospitals University NHS Foundation Trust, Ashford, UK
Data nadesłania: 03-09-2019
Data ostatniej rewizji: 24-09-2019
Data akceptacji: 30-09-2019
Data publikacji online: 31-10-2019
Data publikacji: 19-11-2019
Reumatologia 2019;57(5):277-280
Dryness of mucosa and eyes is the most recognizable symptom of Sjögren’s syndrome (SS). Secondary SS (sSS) is diagnosed when symptoms of SS coexist with other systemic connective tissue disease. The sSS is often identified based on the symptoms of dryness in the presence of other connective tissue disease, making the diagnosis of sSS very subjective. The goal of this work was to summarize previously used and current criteria for the diagnosis of sSS. Classification criteria for sSS, which are universally accepted standards, do not exist. The diagnosis of sSS still depends on the experience of the investigator. Histopathological examination of minor salivary glands appears to be crucial for characterization of patients with sSS due to a specific picture of the disease and repeatability of the test.
Shiboski CH, Shiboski SC, Seror R, et al. 2016 ACR-EULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 2017; 69: 35-45.
Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology Classification Criteria for Sjögren’s Syndrome: A Data-Driven, Expert Consensus Approach in the SICCA Cohort. Arthritis Care Res (Hoboken) 2012; 64: 475-487.
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicenter study. The European Study Group on Diagnostic Criteria for Sjögren’s Syndrome. Ann Rheum Dis1996; 55: 116-121.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease – an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-159.
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl Med 1975; 292: 344-347.
Manoussakis MN, Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 73-95.
Manoussakis MN, Moutsopoulos HM. Update knowledge of dry mouth – A guideline for dentists. Adv Intern Med. 2001; 47:191-217.
Mavragani CP, Moutsopoulos HM. Primary versus Secondary Sjögren Syndrome: Is It Time To Reconsider These Terms? J Rheumatol 2019; 46: 665-666.
Tipu HN, Bashir MM. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing. J Coll Physicians Surg Pak 2018; 28: 40-43.
Sánchez-Montalvá A, Fernández-Luque A, Simeón CP, et al. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study. Clin Exp Rheumatol 2014; 32 (Suppl 86): 177-182.
Defendenti C, Atzeni F, Spina MF, et al. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Rev 2011; 10: 150-154.
Hashemi H, Khabazkhoob M, Kheirkhah A, et al. Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol 2014; 42: 242-248.
Alsakran Altamimi M. Update knowledge of dry mouth- A guideline for dentists. Afr Health Sci 2014; 14: 736-742.
Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International Registry. Am J Ophthalmol 2010; 149: 405-415.
Sebastian A, Markuszewska A, Markuszewski B, et al. Enhanced ocular staining score in patients with primary Sjögren’s syndrome. Klin Oczna 2014; 116: 205-209.
Van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969: 82: 10-14.
Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008: 139: 35-40.
Fisher BA, Jonsson R, Daniels T, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis 2017; 76: 1161-1168.
Wiland P. Panta rhei in diagnosing rheumatic diseases. Reumatologia 2019; 57: 127-128.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top